The key objectives are to support the Trust’s strategy to further grow, communicate its key differentiators, support its financial results, and help bolster the investment case for biotech.
We have been achieving these objectives by securing key, sought after profiles and share tips columns in the nationals [Tempus, The Times circulation – 450,064; unique monthly browsers: 810,961; Fund Focus, Mail on Sunday – circulation: 1,328,581; unique monthly browsers: 27,000,000].
We have positioned the investment managers as key commentators through a regular stream of thought-leadership articles. We have continued to effectively target analysts. In addition, we have advised on marketing materials such as factsheets, the website and social media channels. The programme also supports the Trust’s announcements.
When introducing a dividend policy, our strategy was to proactively brief the media, highlighting the benefits to existing shareholders and potential investors. This resulted in positive coverage in ‘Investment Trust bargain of the week’ in the Sunday Telegraph [circulation 458,272] and intermediary trade publications.
We have continued to leverage the dividend story as part of the programme. Overall, the media and analyst sentiment towards the Trust remains extremely positive.
The UK asset management industry manages over a third of all assets in Europe, with the bulk of those assets being domiciled in Luxembourg and Dublin. Therefore, whilst the inner workings of the asset management industry may not be at the forefront of discussions over a trade agreement between the UK and EU, the implications of a deal or no deal are very substantial. With deadlines being first reset to Sunday December 13 and now lifted, the mood among deal-watchers has become increasingly downbeat.
One of my favourite British bands, James once declared “If I hadn’t seen such riches, I could live with being poor”. Mankind faces a similar problem today; we have become accustomed to the lifestyle that the burning of fossil fuels has allowed us, and we can’t go back.
Get in touch with our experts today.